tiprankstipranks
Trending News
More News >
BioView Ltd. (IL:BIOV)
:BIOV
Israel Market

Bio View (BIOV) Income Statement

Compare
0 Followers

Bio View Income Statement

Last quarter (Q2 2025), Bio View's total revenue was ₪4.63M, a decrease of -45.62% from the same quarter last year. In Q2, Bio View's net income was ₪-2.28M. See Bio View’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
₪ 25.66M₪ 34.77M₪ 29.14M₪ 30.51M₪ 25.96M
Gross Profit
₪ 15.56M₪ 21.38M₪ 16.67M₪ 17.59M₪ 15.78M
Operating Expenses
₪ 18.44M₪ 20.61M₪ 15.52M₪ 14.64M₪ 14.58M
Depreciation and Amortization
₪ 1.70M₪ 1.82M₪ 1.50M₪ 1.48M₪ 1.23M
EBITDA
₪ -943.00K₪ 2.93M₪ 2.61M₪ 4.45M₪ 2.43M
Operating Income
₪ -2.88M₪ 766.00K₪ 1.15M₪ 2.95M₪ 1.20M
Other Income/Expenses
₪ 19.00K₪ 31.00K₪ -276.00K₪ -267.00K₪ -60.00K
Pretax Income
₪ -2.86M₪ 797.00K₪ 875.00K₪ 2.68M₪ 1.14M
Net Income
₪ -3.15M₪ 383.00K₪ 587.00K₪ 2.18M₪ 884.00K
Per Share Metrics
Basic EPS
₪ -0.02₪ 0.00₪ 0.05₪ 0.16₪ 0.06
Diluted EPS
₪ -0.02₪ 0.00₪ 0.05₪ 0.16₪ 0.06
Weighted Average Shares Outstanding
140.07M 135.43M 13.91M 13.98M 14.06M
Weighted Average Shares Outstanding (Diluted)
138.64M 139.08M 13.91M 13.98M 14.06M
Currency in ILS

Bio View Earnings and Revenue History